Hyperbaric Oxygen as Longevity Medicine

Hyperbaric oxygen therapy (HBOT) has established medical uses—treating decompression sickness, carbon monoxide poisoning, non-healing wounds. But longevity clinics now market it for anti-aging, citing studies showing telomere lengthening and senescent cell reduction. The contested leap: do biomarker shifts translate to meaningful health outcomes?

The Biomarker Problem

Several studies have shown that specific HBOT protocols can increase telomere length in immune cells and reduce markers of cellular senescence. These findings are genuinely interesting—telomere shortening and senescent cell accumulation are associated with aging. But association isn't causation, and changing biomarkers isn't the same as changing outcomes.

The fundamental question remains unanswered: does HBOT for longevity actually extend healthspan or lifespan? The studies showing biomarker changes weren't designed to answer this question, and the sample sizes and follow-up periods are inadequate to detect mortality effects.

Why It Matters for Luxury

HBOT for longevity shows how the wellness market responds to emerging science. Real research showing interesting biomarker effects gets translated into consumer products before anyone knows if the effects matter. Clients receive impressive-sounding data about their telomeres; whether that data predicts anything about their future health is genuinely unknown.

Research

Product / Brand Links

News & Coverage